alpha-naphthoflavone has been researched along with glycogen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyerinck, RA; Brass, EP; Garrity, MJ | 1 |
| Jiang, H; Jin, Y; Li, B; Li, D; Wang, Z; Xia, H; Zhang, X; Zhu, X | 1 |
2 other study(ies) available for alpha-naphthoflavone and glycogen
| Article | Year |
|---|---|
Inhibition of prostaglandin E2 catabolism and potentiation of hepatic prostaglandin E2 action in rat hepatocytes by inhibitors of oxidative metabolism.
Topics: Aminopyrine; Animals; Benzoflavones; Dinoprostone; Glucagon; Glycogen; Liver; Male; Metyrapone; Oxidation-Reduction; Proadifen; Prostaglandins E; Rats; Rats, Inbred Strains | 1988 |
Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
Topics: Animals; Benzoflavones; Catalase; Cell Proliferation; Diet, High-Fat; Glycogen; Hep G2 Cells; Hepatocytes; Humans; Insulin Resistance; Lipid Droplets; Lipid Metabolism; Liver; Male; Malondialdehyde; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidative Stress; Superoxide Dismutase | 2019 |